SCHEMBL27614616

SCHEMBL27614616

Clc1cccc(CCNCc2cccc(-c3cncnc3)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ SCN8A Q9UQD0 1/20 0.54
▸ CHRM2 P08172 1/20 0.52
▸ HDAC1 Q13547 1/20 0.49
▸ TAAR1 Q96RJ0 1/20 0.47
▸ NOS1 P29475 5/20 0.45
▸ NOS3 P29474 4/20 0.45
▸ NOS2 P35228 2/20 0.45
▸ NR1I3 Q14994 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27614687 0.88 EPHX2 (0.57) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL5947233 0.81 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL28753877 0.81 ROCK1 (0.53) SCN8ATAAR1MEN1KMT2ACNR1
SCHEMBL27614768 0.77 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL25584988 0.76 SCN8A (0.59) CYP1A2CYP3A4CYP2D6CYP2C19SCN8A
SCHEMBL2538044 0.75 CYP1A2 (0.62) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL27684280 0.74 ATM (0.54) TAAR1CNR1CNR2
SCHEMBL7774786 0.74 CHRM2 (0.81) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL27614836 0.74 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2
SCHEMBL5947316 0.73 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1610547-A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor LILLY CO ELI (US) 2005-04-27 — — CN claimed
Send feedback